Clinical trial
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational…
NCT00043901 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00043901 |
|---|---|
| Title | Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug |
| Official title | A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects Wtih Primary Generalized Tonic-Clonic Seizures |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy, Tonic-Clonic |
| Intervention type | Drug |
| Interventions | lamotrigine |
| Enrollment | 141 |
| Start date | Dec 1, 2000 |
| Primary completion | Nov 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Aug 16, 2002 |
| Last update posted | Apr 4, 2017 |
| Countries | Argentina, Chile, Peru, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: